PVLA
Palvella Therapeutics (PVLA)
$18
About Palvella Therapeutics (PVLA)
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. It develops a pipeline of treatments for rare genetic skin diseases using its patented QTORIN platform. The company was founded in 2015 and is headquartered in Wayne, PA.
Details
Daily high
$128.00
Daily low
$121.47
Price at open
$128.00
52 Week High
$151.18
52 Week Low
$20.20
Market cap
1.8B
Dividend yield
0.00%
Volume
268,731
Avg. volume
266,577
P/E ratio
-34.70
Palvella Therapeutics News
Details
Daily high
$128.00
Daily low
$121.47
Price at open
$128.00
52 Week High
$151.18
52 Week Low
$20.20
Market cap
1.8B
Dividend yield
0.00%
Volume
268,731
Avg. volume
266,577
P/E ratio
-34.70